SK

Sriprakash Krishnan

Director Director DIN 06952501
DIN 06952501 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 3 historical roles
Total affiliations 3 Since Sep 2014
Shareholding value •••• Premium profile

About Sriprakash Krishnan

Data last updated:

Sriprakash Krishnan was a Director at Amishi Drugs And Chemicals Private Limited (2022–2026), Director at Ingredion India Private Limited (2014–2026) and Director at Mannitab Pharma Specialities Private Limited (2022–2025). The companies operate in Pharma and Chemicals and Materials.

DIN 06952501
Primary Designation Director
Industry Pharma
First Appointment 17 Sep 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20222005₹41.08 Cr (FY 2025)Active
Ingredion India Private Limited U51101MH2010PTC208697
Director17 Sep 20142010₹230 Cr (FY 2025)Active
Director01 Dec 20222022₹123 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Amishi Drugs And Chemicals Private Limited
Ingredion India Private Limited
Mannitab Pharma Specialities Private Limited
Premium access

Shareholding and investment profile for Sriprakash Krishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sriprakash Krishnan

Sriprakash Krishnan was first appointed on 17 Sep 2014 as Director at Ingredion India Private Limited. The most recent appointment on record is 01 Dec 2022 at Mannitab Pharma Specialities Private Limited.

Sriprakash Krishnan held 3 earlier board appointments: Amishi Drugs And Chemicals Private Limited (Director, 01 Aug 2022 to 19 Jan 2026); Ingredion India Private Limited (Director, 17 Sep 2014 to 09 Jan 2026); Mannitab Pharma Specialities Private Limited (Director, 01 Dec 2022 to 30 Nov 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available